- Bloomberg•2 days ago
AstraZeneca Plc said it had a key lung cancer drug approved in China, opening up a new market for the therapy and allowing U.K.’s second-biggest drugmaker to reach thousands of new patients in country ...
- Zacks•3 days ago
Shares of London-based pharma giant, AstraZeneca plc (AZN) have risen 13.4% this year so far, while the Zacks classified Large-Cap Pharma industry increased 6.4%.
- Market Realist•4 days ago
On December 9, 2016, the FDA accepted for review its first-ever biologics license application (or BLA) submitted by AstraZeneca (AZN).
AZN : Summary for Astrazeneca PLC - Yahoo Finance
AstraZeneca PLC (AZN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||31.10 - 31.38|
|52 Week Range||25.55 - 35.04|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||22.69|
|Dividend & Yield||1.90 (6.07%)|
|1y Target Est||N/A|